Correction: SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI)

Affiliations

• ¹ Clinical Cardiology and Cardiovascular Imaging Unit, IRCCS Galeazzi-Sant'Ambrogio Hospital, Milan, Italy.
• ² Cardiovascular Center Aalst, OLV-Clinic, Aalst, Belgium.
• ³ Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy.
• ⁴ Cardiovascular Department, Azienda Ospedaliero Universitaria Integrata di Verona, Verona, Italy.
• ⁵ Unit of Cardiology, Department of Medical and Surgical Sciences (DIMEC), Sant'Orsola-Malpighi Hospital, IRCCS, University of Bologna, Bologna, Italy.
• ⁶ Interventional Cardiology Unit, De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy.
• ⁷ Division of Cardiology, A.O.R.N. "Sant'Anna e San Sebastiano", Caserta, Italy.
• ⁸ Department of Translational Medical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.
• ⁹ Cardiology Division, IRCCS Galeazzi-Sant'Ambrogio Hospital, Milan, Italy.
• ¹⁰ Division of Cardiology, Sant'Andrea Hospital, Rome, Italy.
• ¹¹ Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
• ¹² Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
• ¹³ Division of Cardiology, Sant'Andrea Hospital, Rome, Italy. [email protected].
• ¹⁴ Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy. [email protected].